HOTH
NASDAQ · Pharmaceuticals
Hoth Therapeutics Inc
$0.90
+0.02 (+1.77%)
Financial Highlights (FY 2025)
Revenue
4.55M
Net Income
883.9K
Gross Margin
33.9%
Profit Margin
19.4%
Rev Growth
+13.3%
D/E Ratio
0.67
Revenue & Net Income
Margin Trends
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Gross Margin | 33.9% | 33.9% | 33.9% |
| Operating Margin | 19.2% | 21.3% | 18.9% |
| Profit Margin | 19.4% | 20.6% | 15.9% |
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.55M | 4.47M | 5.09M |
| Gross Profit | 1.54M | 1.51M | 1.72M |
| Operating Income | 872.4K | 950.5K | 961.4K |
| Net Income | 883.9K | 919.3K | 807.7K |
| Gross Margin | 33.9% | 33.9% | 33.9% |
| Operating Margin | 19.2% | 21.3% | 18.9% |
| Profit Margin | 19.4% | 20.6% | 15.9% |
| Rev Growth | +13.3% | +17.8% | +20.0% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 3.76M | 4.02M | 3.76M |
| Total Equity | 5.62M | 6.75M | 6.78M |
| D/E Ratio | 0.67 | 0.60 | 0.55 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 1.12M | 1.15M | 1.14M |
| Free Cash Flow | 1.08M | 1.03M | 790.7K |